Ondo InsurTech PLC Block Listing Application - Amendment

RNS Number : 0137R

Ondo InsurTech PLC

20 December 2024

 

The announcement headed "Block Listing Application released at 15.12 under RNS No 9950Q stated that the Block Listing is expected to become effective on 31 December 2024.  This date should read 6 January 2025.

 

All other details remain unchanged

 

 

20 December 2024

 

Ondo InsurTech plc

("Ondo" or the "Company")

 

Block Listing Application

 

 

Ondo InsurTech plc (LSE: ONDO), announces that application has been made to the Financial Conduct Authority and to London Stock Exchange plc for 10,441,618 ordinary shares of 5 pence each in Company (the "New Option Shares") to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange under a block listing (the "Block Listing").

 

The Block Listing application relates to New Option Shares to be issued from time to time to satisfy the allotment of shares pursuant to share options awarded previously to employees and certain Directors of the Company under the Company's Enterprise Management Incentive Share Option Plan and other unapproved share options. 

 

The Block Listing is expected to become effective on 6 January 2025.  When issued, the New Option Shares will rank pari passu with the Company's existing issued ordinary shares.

 

Enquiries

 

For further information, please visit www.ondoplc.com or contact the following:  

 

Ondo InsurTech Plc	Craig Foster, CEO Kevin Withington, CFO	[phone]
Dowgate Capital Limited (Broker & Financial Advisor)	Russell Cook Nicholas Chambers Charlie Hall	[phone]
Cassiopeia Services Limited (PR & Investor Relations)	Stefania Barbaglio	[phone]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

ALSDBLFLZLLZFBV